Delivery Order SPE2DB20D3104-SPE2DB25FV9P4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,111.23 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100 count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $10,159.18 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 17, 2025, and was awarded on September 16, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,374.34 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,381.25 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30, with an ultimate completion date of August 7, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $11,112.30 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (100-count units) with a completion date of July 31, 2025. This firm fixed-price, non-set-aside contract was awarded on July 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract is valued at $1,510.57 with a firm fixed price structure and an ultimate completion date of August 19, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,686.34 delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This is a firm fixed price contract with an ultimate completion date of September 5, 2025, and represents a competitively awarded, non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $14,842.16 delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supply support to federal healthcare...
- The Defense Logistics Agency awarded a $5,047.33 delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (90-count units) on August 18, 2025, with completion due by August 19, 2025. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order for pharmaceutical products to be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $5,056.95 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). The contract is a firm fixed price delivery order with an ultimate completion date of September 4, 2025, and was awarded on September 3, 2025. This non-set-aside award was competitively awarded, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The place of...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV9P4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,628.05 to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count packaging) on August 15, 2025, with an ultimate completion date of August 18, 2025. The contract utilizes firm fixed-price pricing and was awarded on a non-set-aside, competitive basis. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply an extensive range of pharmaceutical products and medical commodities to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare supplies. The company's extensive federal contracting history demonstrates its capability to meet diverse medical supply requirements across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard. This terbinafine order represents a routine pharmaceutical delivery under the company's established relationship with DLA Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/15/25 |